Published in
American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 2(63), 2019
DOI: 10.1128/aac.01489-18
Links
Tools
Evaluation of Carbapenems for Treatment of Multi- and Extensively Drug-Resistant Mycobacterium tuberculosis
Journal article published in 2018 by
Sander P. van Rijn,
Marlanka A. Zuur,
Richard Anthony,
Bob Wilffert,
Richard van Altena,
Onno W. Akkerman 
,
Wiel C. M. de Lange,
Tjip S. van der Werf,
Jos G. W. Kosterink,
Jan-Willem C. Alffenaar
,
Wiel C. M. de Lange,
Tjip S. van der Werf,
Jos G. W. Kosterink,
Jan-Willem C. Alffenaar
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Data provided by 
Abstract
Multi- and extensively drug-resistant tuberculosis (M/XDR-TB) has become an increasing threat not only in countries where the TB burden is high but also in affluent regions, due to increased international travel and globalization. Carbapenems are earmarked as potentially active drugs for the treatment of Mycobacterium tuberculosis .